These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 17028294

  • 21. Tissue and serum biomarkers as prognostic variables in endometrioid-type endometrial cancer.
    Gadducci A, Cosio S, Genazzani AR.
    Crit Rev Oncol Hematol; 2011 Nov; 80(2):181-92. PubMed ID: 21134766
    [Abstract] [Full Text] [Related]

  • 22. Precursors of endometrial clear cell carcinoma.
    Fadare O, Liang SX, Ulukus EC, Chambers SK, Zheng W.
    Am J Surg Pathol; 2006 Dec; 30(12):1519-30. PubMed ID: 17122507
    [Abstract] [Full Text] [Related]

  • 23. Endometrial glandular dysplasia with frequent p53 gene mutation: a genetic evidence supporting its precancer nature for endometrial serous carcinoma.
    Jia L, Liu Y, Yi X, Miron A, Crum CP, Kong B, Zheng W.
    Clin Cancer Res; 2008 Apr 15; 14(8):2263-9. PubMed ID: 18369088
    [Abstract] [Full Text] [Related]

  • 24. Molecular genetics and endometrial cancer.
    Oehler MK, Brand A, Wain GV.
    J Br Menopause Soc; 2003 Mar 15; 9(1):27-31. PubMed ID: 12804310
    [Abstract] [Full Text] [Related]

  • 25. Progressive derailment of cell cycle regulators in endometrial carcinogenesis.
    Horrée N, van Diest PJ, van der Groep P, Sie-Go DM, Heintz AP.
    J Clin Pathol; 2008 Jan 15; 61(1):36-42. PubMed ID: 17483252
    [Abstract] [Full Text] [Related]

  • 26. Intratumoral genetic heterogeneity and progression of endometrioid type endometrial adenocarcinomas.
    Faquin WC, Fitzgerald JT, Boynton KA, Mutter GL.
    Gynecol Oncol; 2000 Aug 15; 78(2):152-7. PubMed ID: 10926795
    [Abstract] [Full Text] [Related]

  • 27. Molecular pathology of endometrial carcinoma.
    Matias-Guiu X, Prat J.
    Histopathology; 2013 Jan 15; 62(1):111-23. PubMed ID: 23240673
    [Abstract] [Full Text] [Related]

  • 28. Involvement of the ras genes in female genital tract cancer.
    Mammas IN, Zafiropoulos A, Spandidos DA.
    Int J Oncol; 2005 May 15; 26(5):1241-55. PubMed ID: 15809715
    [Abstract] [Full Text] [Related]

  • 29. Carcinogenic mechanisms of endometrial cancer: involvement of genetics and epigenetics.
    Banno K, Yanokura M, Iida M, Masuda K, Aoki D.
    J Obstet Gynaecol Res; 2014 Aug 15; 40(8):1957-67. PubMed ID: 25131761
    [Abstract] [Full Text] [Related]

  • 30. Endometrial glandular dysplasia and endometrial intraepithelial neoplasia.
    Yi X, Zheng W.
    Curr Opin Obstet Gynecol; 2008 Feb 15; 20(1):20-5. PubMed ID: 18197001
    [Abstract] [Full Text] [Related]

  • 31. Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
    Lax SF.
    Virchows Arch; 2004 Mar 15; 444(3):213-23. PubMed ID: 14747944
    [Abstract] [Full Text] [Related]

  • 32. Genome-wide mutation analysis in precancerous lesions of endometrial carcinoma.
    Li L, Yue P, Song Q, Yen TT, Asaka S, Wang TL, Beavis AL, Fader AN, Jiao Y, Yuan G, Shih IM, Song Y.
    J Pathol; 2021 Jan 15; 253(1):119-128. PubMed ID: 33016334
    [Abstract] [Full Text] [Related]

  • 33. [The premalignant disease of the endometrium: endometrial intraepithelial neoplasia].
    Francz M.
    Magy Onkol; 2008 Mar 15; 52(1):35-40. PubMed ID: 18403295
    [Abstract] [Full Text] [Related]

  • 34. Pathogenetic pathways in ovarian endometrioid adenocarcinoma: a molecular study of 29 cases.
    Geyer JT, López-García MA, Sánchez-Estevez C, Sarrió D, Moreno-Bueno G, Franceschetti I, Palacios J, Oliva E.
    Am J Surg Pathol; 2009 Aug 15; 33(8):1157-63. PubMed ID: 19542870
    [Abstract] [Full Text] [Related]

  • 35. Endometrial carcinoma tumorigenesis and pharmacotherapy research.
    Shu J, Fang S, Teichman PG, Xing L, Huang H.
    Minerva Endocrinol; 2012 Jun 15; 37(2):117-32. PubMed ID: 22691886
    [Abstract] [Full Text] [Related]

  • 36. Utilization of unlabeled probes for the detection of fibroblast growth factor receptor 2 exons 7 and 12 mutations in endometrial carcinoma.
    Liu T, Willmore-Payne C, Wallander ML, Layfield LJ.
    Appl Immunohistochem Mol Morphol; 2011 Jul 15; 19(4):341-6. PubMed ID: 21285871
    [Abstract] [Full Text] [Related]

  • 37. Inflammation and endometrial cancer: a hypothesis.
    Modugno F, Ness RB, Chen C, Weiss NS.
    Cancer Epidemiol Biomarkers Prev; 2005 Dec 15; 14(12):2840-7. PubMed ID: 16364998
    [Abstract] [Full Text] [Related]

  • 38. Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways.
    Wu R, Hendrix-Lucas N, Kuick R, Zhai Y, Schwartz DR, Akyol A, Hanash S, Misek DE, Katabuchi H, Williams BO, Fearon ER, Cho KR.
    Cancer Cell; 2007 Apr 15; 11(4):321-33. PubMed ID: 17418409
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.